[1]
“Rituximab to Abbreviate Plasma Exchange in Anti-CFH (Complement Factor H) Antibody Mediated Atypical HUS”, IJKD, vol. 13, no. 2, pp. 134–138, Apr. 2019, Accessed: Dec. 22, 2024. [Online]. Available: https://ijkd.org/index.php/ijkd/article/view/4138